Emedinova Marketing Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 12.30%
- Profit Growth -84.43%
- Ebitda -82.57%
- Net Worth 159.41%
- Total Assets 78.78%
About Emedinova Marketing
Emedinova Marketing Private Limited (EMPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 July 2018 (Six years and six months 17 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Roushan and Surbhi Raj serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85100BR2018PTC038822
-
Company No.
038822
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Jul 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Emedinova Marketing?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Roushan
|
Director | 31-Jul-2018 | Current |
|
Surbhi Raj
|
Director | 31-Jul-2018 | Current |
Financial Performance of Emedinova Marketing.
Emedinova Marketing Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.3% increase. The company also saw a substantial fall in profitability, with a 84.43% decrease in profit. The company's net worth Soared by an impressive increase of 159.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emedinova Marketing?
Unlock access to Emedinova Marketing's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Omyaa Pharmaceuticals Private LimitedRakesh Roushan is a mutual person
-
Namobudham Hospital Private Limited
Rakesh Roushan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Emedinova Marketing?
Emedinova Marketing has a workforce of 22 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emedinova Marketing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emedinova Marketing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
